past performance does not play on this
1- trump is the president
2- bpmx, even though its up, is underperforming the market by 30%
3- the time from proposed drug to actual drug is 2/3 over, closer to realization.
4- pp of the drug is 100% and looks GREEN as hell
5- not a new drug, existing drug new application method, using 90% less drug thats NOT ingested
6- taking on a 450 million a year market that it can dominate
yeah,,,experts, listen to them and their charts, will cost you tons of money.